[Clinical and economic impact of the pharmacy resident incorporation into the healthcare team]. / Impacto clínico y económico de la incorporación del farmacéutico residente en el equipo asistencial.

OBJECTIVE: To quantify the impact of the incorporation of a hospital pharmacy resident into a healthcare team. To describe the work schedule followed. METHOD: The resident was integrated for 8 months in Medical Oncology, Intensive Care Unit, and Oncology Day Hospital. Interventions were recorded and evaluated using Atefarm software. Problem characteristics, type, and severity were recorded, as were acceptance, and costs avoided by interventions. RESULTS: In all, 2,415 drug-related problems were detected (10 per day, and 3.6 per patient), and 2,545 interventions for 672 patients were carried out. Most common problems were inadequate treatment duration, and conversion to oral route. Sixty-one percent of errors were prevented. Sixty-five percent of interventions influenced safety, 35% efficiency, and 25% effectiveness. Ninety-four percent of interventions were accepted. Costs avoided by the pharmacist amounted to 3,133 euro per month. CONCLUSIONS: The integration of a pharmacist in the healthcare teams optimizes therapy, reduces costs, prevents adverse events, and offers healthcare education.

Impacto clínico y económico de la incorporación del farmacéutico residente en el equipo asistencial / No disponible

Objetivo: Cuantificar el impacto de la integración de un residentede Farmacia Hospitalaria en el equipo asistencial. Describirla sistemática de trabajo seguida.Método: El residente se integró durante 8 meses en oncologíamédica, unidad de cuidados intensivos y hospital de día de oncología.Las intervenciones se registraron y evaluaron mediante elprograma informático Atefarm®. Se registraron las características,tipo y gravedad de los problemas y la aceptación y coste evitadode las intervenciones.Resultados: Se detectaron 2.415 problemas relacionadoscon los medicamentos (10 por día y 3,6 por paciente) y se realizaron2.545 intervenciones sobre 672 pacientes. Los más frecuentesfueron la inadecuada duración de los tratamientos y la conversióna vía oral. El 61% de los errores fueron prevenidos. Un 65%de las intervenciones tuvo impacto sobre seguridad, 35% sobreeficiencia y 25% sobre efectividad. El 94% de las intervencionesfueron aceptadas. El coste evitado por farmacéutico/mes ascendióa 3.133 €.Conclusiones: El farmacéutico integrado en los equipos asistencialesoptimiza la terapia, reduce costes, previene efectosadversos y ofrece educación sanitaria

Objective: To quantify the impact of the incorporation of ahospital pharmacy resident into a healthcare team. To describethe work schedule followed.Method: The resident was integrated for 8 months in MedicalOncology, Intensive Care Unit, and Oncology Day Hospital. Interventionswere recorded and evaluated using Atefarm®‚ software.Problem characteristics, type, and severity were recorded, as wereacceptance, and costs avoided by interventions.Results: In all, 2,415 drug-related problems were detected(10 per day, and 3.6 per patient), and 2,545 interventions for672 patients were carried out. Most common problems wereinadequate treatment duration, and conversion to oral route. Sixty-one percent of errors were prevented. Sixty-five percent ofinterventions influenced safety, 35% efficiency, and 25% effectiveness.Ninety-four percent of interventions were accepted.Costs avoided by the pharmacist amounted to 3,133 per month.Conclusions: The integration of a pharmacist in the healthcareteams optimizes therapy, reduces costs, prevents adverseevents, and offers healthcare education